查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1864170

治疗性低温系统市场按产品类型、冷却方式、应用、最终用户和温度控制类型划分－2025-2032年全球预测

Therapeutic Hypothermia Systems Market by Product Type, Cooling Method, Application, End User, Temperature Control Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，治疗性低温系统市场将成长至 5.5196 亿美元，复合年增长率为 6.91%。

关键市场统计数据
基准年 2024 3.2331亿美元
预计年份：2025年 3.4529亿美元
预测年份 2032 5.5196亿美元
复合年增长率 (%) 6.91%

这篇引人入胜的引言阐述了临床预期、技术进步和营运需求如何融合，共同塑造治疗性低温系统的未来。

治疗性低温系统在加护治疗创新和实证临床通讯协定的交会点发挥着至关重要的作用。过去十年，临床界已普遍支持将目标温度管理（TTM）作为某些神经系统疾病和復苏后适应症的基石干预措施。这促使医疗设备製造商和医院技术团队优先考虑更安全、更精准的降温方法。在此背景下，相关人员努力应对日益复杂的局面，临床疗效、操作便捷性、与医院工作流程的整合以及监管政策的清晰度等因素将决定其推广应用的进展。

临床医生现在期望医疗设备能够提供精确的温度控制，快速达到治疗目标，并最大限度地减少对其他同期手术的干扰。同时，技术创新和材料科学的进步催生了创伤较小的表面冷却方案和先进的血管内导管，每种方案都有其独特的临床优缺点。此外，医疗系统面临着透过改善患者预后和简化诊疗流程来证明其价值的压力，因此，医疗设备的选择决策不再由单一的采购部门做出，而是由多学科委员会共同製定。最终，采购决策将基于临床数据对比、与温度监测系统的兼容性以及长期可维护性等因素。

展望未来，互通平台的普及和多中心临床项目证据的不断改进将继续影响采购标准。标准、报销政策和临床医生培训方面的过渡性发展可能会凸显全面实施计划的重要性。因此，决策者必须仔细权衡临床效益和营运影响，以确保设备应用能够带来可衡量的临床改善。

不断发展的临床证据、医疗设备创新和医院营运重点如何重塑治疗性低温系统的采购和部署

治疗性低温疗法领域经历了许多变革，这些变革的驱动力包括临床证据、医疗设备创新和系统层面的迫切需求。首先，临床实践已从广泛应用转向基于随机对照试验和更细緻的指南更新的、更有针对性的体温管理，这些指南更新强调患者选择和治疗时机。这种临床实践的精细化提高了医疗设备性能的标准；精确性、快速指导和可控復温已成为核心差异化因素。

其次，技术进步拓展了器械的套件。导管设计、热交换效率和表面冷却材料的改进，使得器械能够应用于更广泛的临床场景，并降低手术风险。同时，数位化整合，例如电子病历整合和远端监测功能，正在逐步提高工作流程效率，并加强对通讯协定的遵循。这些能力正在改变采购讨论的焦点，使人们的关注点从单一装置的功能转向平台层面的相容性和全生命週期服务。

第三，医院内部的营运现实，例如重症监护室容量限制和对感染预防日益重视，正在加速人们对微创模组化降温解决方案的兴趣。医院正日益评估治疗性低温系统如何融入更广泛的医疗计画中，例如復苏、加护治疗和手术全期管理。因此，临床医生、生物医学工程团队和供应链负责人之间的合作变得更加策略性，除了整体拥有成本和实施支持外，还强调临床效益的证据。这些变化正在共同重塑产业相关人员和临床采用者的预期。

评估受2025年关税调整影响的製造商和医疗保健提供者的短期供应链调整和策略采购转变

2025年公布的关税调整为医疗设备製造商、分销网路和医疗保健系统带来了新的复杂性，影响了跨境供应链和筹资策略。为此，製造商重新评估了製造地、筹资策略和定价模式，以在应对利润压力的同时维持供应的连续性。对于医院和采购联盟而言，眼前的挑战是重新评估竞标规范并加强本地库存缓衝，以缓解潜在的前置作业时间波动。

这些变化正推动近期商业性结构调整以降低关税风险，包括重新谈判分销合约以及扩大区域组装和最终配置中心的使用。同时，医疗设备开发商正加强实现关键零件（例如导热介面材料和电子元件）的在地采购或寻找替代供应商。在营运方面，临床团队和采购负责人越来越关注总落地成本和物流风险，并将关税风险纳入多年资本规划。

从中长期来看，关税环境促使相关人员探索创造性的合约方式，包括基于价值的采购协议和联合采购，以充分利用规模经济。此外，人们也更加关注旨在延长设备使用寿命和抵消资本支出的服务协议和再製造项目。最终，儘管关税造成了短期摩擦，但也加速了围绕近岸外包、库存弹性以及采购多元化等战略议题的讨论，从长远来看，这有可能加强供应链。

深度細項分析揭示了产品类型、冷却方式、临床应用、最终用户和温度控制方法如何驱动差异化的设备策略和临床应用。

细分市场分析揭示了治疗性低温领域中不同的应用模式和产品策略，反映了不同的临床需求和操作限制。产品类型差异涵盖频谱广泛，从毯子和垫片系统到水循环系统、冰袋和凝胶袋，其中基于导管的系统在侵入性靶向降温领域占据重要地位。在基于导管的降温方法中，球囊导管和液体导管的插入方式和热交换机制各不相同，这会影响在严重监护环境下临床医生的选择。

在降温方法领域，血管内降温与体表降温之间存在明显的技术差异。血管内装置能够直接调节核心体温，而体表降温方法，例如毯式降温系统、冰袋/凝胶袋、垫片降温系统和水循环系统，则提供了非侵入性的选择，可以轻鬆整合到现有的工作流程中。按应用领域划分，突显了推动需求的临床应用场景。虽然心臟麻痹和新生儿脑病变仍然是体温管理的重点场景，但术后护理、中风和创伤性脑损伤等领域也在不断评估低温通讯协定在神经保护和优化復健方面的应用。

终端使用者细分突显了实施复杂性和采购权限的差异：门诊中心、居家医疗机构、医院和专科诊所，每个机构的营运能力和临床人员配备各不相同。温度控制类型细分突显了受控温度管理和非受控冷却之间的区别，前者进一步细分为目标性低温和目标常温策略，这两种策略需要不同的设备控製粒度和警报管理。总而言之，这些细分观点突显了临床适应症、护理环境和首选冷却方式如何相互作用，从而决定设备的选择和商业化策略。

从区域比较的观点来看，不同的监管、临床和供应链趋势正在塑造美洲、欧洲/中东/非洲和亚太地区的医疗器材采用路径。

区域趋势涵盖美洲、欧洲、中东和非洲以及亚太地区，各地区有不同的驱动因素，影响医疗器材的普及、报销和供应链策略。在美洲，先进的加护治疗基础设施和一体化的采购网络促进了高成本精密医疗设备的快速普及。区域性復苏后护理卓越中心通常在实证实践的生成和最佳实践的推广方面主导。因此，采购流程通常会纳入临床结果数据，并且需要完善的服务和培训系统来支援大型医院系统的应用。

同时，欧洲、中东和非洲地区各市场的法规结构和报销途径差异显着，影响商业化策略。许多欧洲、中东和非洲国家的公共医疗采购强调长期价值和互通性，要求製造商证明其产品能够整合工作流程并提供可持续的服务计划。此外，区域临床协会和合作研究网络在製定指南医疗器材选择的指南方面也发挥着重要作用。

在亚太地区，急诊护理能力的快速提升，以及对新生儿和加护治疗服务投入的增加，催生了对扩充性、高性价比降温解决方案的强劲需求。供应链本地化和区域伙伴关係正被广泛用于缩短前置作业时间，并使定价模式适应不同的市场细分。在整个亚太地区，跨国临床研究合作和共用註册库正在促进建立更一致的证据标准，进而支持最佳实践和技术的广泛传播。

对治疗性低温疗法公司的竞争原型、策略重点与伙伴关係模式进行客观检验，以界定其竞争与合作格局。

治疗性低温领域的竞争动态凸显了产业参与者的三种策略类型：大型多元化医疗设备公司凭藉其规模和服务网路优势；专注于核心冷却技术的专业设备製造商；以及推动材料和软体创新的敏捷型Start-Ups。大型公司往往能够赢得企业级合同，优先考虑与医院基础设施的无缝整合、全面的培训计划和完善的售后服务支援。它们也重视合规性和全球分销，从而能够进行广泛的临床试验和多市场部署。

专业製造商专注于改善热交换效率、导管设计和表面冷却的人体工学，瞄准临床细分市场，在这些市场中，技术性能的提升能够转化为可衡量的治疗效果改善。这些公司通常与领先的临床中心密切合作，以检验设备疗效并完善通讯协定。同时，Start-Ups更倾向于推出颠覆性概念，例如创新热交换材料、用于混合冷却策略的模组化系统以及提供先进自动化和分析功能的温度管理软体驱动控制系统。

在这些典型案例中，策略重点都集中在可证实的临床效益、具有成本效益的服务模式以及透过品质系统和监管途径进行风险管理等方面。医疗器材公司与临床网路之间的伙伴关係，以及租赁、翻新和按绩效付费合约等创造性商业模式，正被越来越多地用于推动产品应用，并将商业性奖励与临床结果相结合。

为製造商和医疗保健领导者提供切实有效的建议，以促进安全应用、增强供应链韧性并展示治疗性低温的临床价值。

行业领导者应促进协作，在临床疗效、操作适用性和财务永续性之间取得平衡，以扩大产品应用范围并改善患者预后。首先，製造商应优先考虑互通性和以临床医生为中心的设计，确保设备能够与监测平台和电子健康记录系统集成，从而减轻认知负荷并提高通讯协定的依从性。投资于模组化产品架构和可扩展的培训项目，能够针对不同的医疗环境进行快速定制，从而加快产品部署后发挥临床作用的速度。

第二，相关人员应透过多中心註册研究及反映真实临床实务的实用性研究，深化临床证据的累积。此类证据将有助于在疗效有争议的适应症中推广应用，并为支付方和采购委员会评估长期价值提供参考。第三，应采取零件供应商多元化和区域组装策略，以降低关税和运输风险，并增强供应链韧性。诸如按绩效付费合约和服务捆绑定价等合约创新，可以协调医疗服务提供者和供应商之间的奖励，并有助于提高高效能係统的可及性。

最后，医疗系统和供应商应携手合作，制定一套标准化的实施套件，其中包括训练课程、通讯协定范本和审核机制。这些资源将减少临床实践中的差异，并加速安全、一致的实施。透过将技术改进与营运支援和实证实践相结合，行业领导者可以将治疗性低温系统定位为加护治疗路径中值得信赖且影响深远的组成部分。

采用透明的混合方法调查方法，结合临床医师访谈、技术评估和供应链分析，确保获得可靠且可操作的见解。

本调查方法采用混合方法，对临床实务模式、技术趋势和供应链趋势进行三角验证。主要数据透过临床主任、医疗设备工程师、采购负责人和产品经理的结构化访谈收集，并辅以在典型临床环境中对装置应用的观察评估。次要资料包括同侪审查的临床文献、监管申报文件、器械使用说明书和技术白皮书（其中定义了器械的运行原理和性能特征）。

我们的分析方法包括对访谈记录进行定性编码，以识别实施过程中遇到的挑战和优先主题，以及进行技术比较评估，以评估设备的功能特性和控制能力。我们的供应链分析检验了关税措施、公开的进出口数据以及製造商关于製造地搬迁和分销商协议的公告。在整个过程中，我们透过交叉引用独立资讯来源并与关键知情人士核实，进行合理性检验，以减少偏见并确保事实准确性。

报告明确指出了其局限性，包括临床实践的区域差异以及特定应用领域证据的不断演变。在适用情况下，报告透过敏感性分析对建议进行了仔细调整，以确保其在各种不同的营运和监管环境下仍然有效。

总结结论认为，临床整合、实施的严谨性和策略性商业化是治疗性低温领域成功的关键因素。

总之，治疗性低温系统正处于策略转折点，临床成熟度、技术创新和营运需求在此交会融合。该领域未来的发展轨迹不仅取决于设备本身的性能，还取决于製造商和医疗系统能否将该技术整合到诊疗路径中、产生真实世界证据并应对复杂的供应链。那些能够使产品设计与临床医生工作流程相契合、加强实施支持并积极参与协作式证据生成的机构，将更有可能取得成功。

在营运层面，采用系统化方法（包括规范通讯协定、员工培训和实施后审核）的医院更有可能获得持续的临床效益。在商业层面，注重互通性、服务可靠性和弹性合约的供应商将赢得高层采购委员会的支持。最后，政策和报销的清晰度将成为关键驱动因素，因为支付方认识到改善神经系统疾病预后和减少长期照护需求的潜力。在这些关键的相互关联问题上采取果断行动的相关人员将更有利于把前景广阔的技术转化为患者照护可衡量的改进。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合自动温度控制和即时病患监测，以提高神经保护的准确性
  • 开发携带式可穿戴治疗性低温设备，用于院外紧急医疗环境
  • 利用尖端材料进行非侵入性冷却技术，实现目标器官保存
  • 新兴的AI驱动通讯协定可根据个别患者的代谢特征优化冷却速率。
  • 扩大全球报销框架，以支持心臟麻痹后护理中的治疗性低温疗法
  • 一项评估联合药物治疗和低温疗法协同神经保护作用的临床试验
  • 医疗设备製造商与医疗保健系统建立策略联盟，以简化低温疗法的输送流程

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的治疗性低温系统市场

  • 毛毯系统
  • 基于导管的系统
    • 球囊导管
    • 液态导管
  • 冰袋和凝胶袋
  • 垫片系统
  • 水循环系统

9. 依冷却方式分類的治疗性低温系统市场

  • 血管内冷却
  • 表面冷却
    • 毛毯系统
    • 冰袋和凝胶袋
    • 垫片系统
    • 水循环系统

第十章 按应用分類的治疗性低温系统市场

  • 心臟麻痹
  • 新生儿脑病变
  • 术后
  • 中风
  • 创伤性脑损伤

第十一章 以最终用户分類的治疗性低温系统市场

  • 门诊治疗中心
  • 居家医疗环境
  • 医院
  • 专科诊所

第十二章 依温度控制类型分類的治疗性低温系统市场

  • 温度控制
    • 标靶低温疗法
    • 有针对性的正常体温管理
  • 不受控制的冷却

13. 各地区治疗性低温疗法系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 治疗性低温系统市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国治疗性低温疗法系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Stryker Corporation
    • CR Bard, Inc.
    • ZOLL Medical Corporation
    • B. Braun Melsungen AG
    • Dragerwerk AG & Co. KGaA
    • Koninklijke Philips NV
    • Fisher & Paykel Healthcare Corporation Limited
    • Haemonetics Corporation
    • Arizant Healthcare Inc.
    • Cincinnati Sub-Zero Products, Inc.
Product Code: MRR-647F3A880AF7

The Therapeutic Hypothermia Systems Market is projected to grow by USD 551.96 million at a CAGR of 6.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 323.31 million
Estimated Year [2025] USD 345.29 million
Forecast Year [2032] USD 551.96 million
CAGR (%) 6.91%

A high-impact introduction framing how clinical expectations, engineering advances, and healthcare operational imperatives together shape the future of therapeutic hypothermia systems

Therapeutic hypothermia systems occupy a pivotal role at the intersection of critical care innovation and evidence-based clinical protocols. Over the past decade, the clinical community has coalesced around targeted temperature management as a cornerstone intervention for select neurological and post-resuscitation indications, prompting device manufacturers and hospital technology teams to prioritize safer, more precise cooling modalities. Against this backdrop, stakeholders are navigating an increasingly complex landscape where clinical efficacy, ease of use, integration with hospital workflows, and regulatory clarity determine adoption trajectories.

Clinicians now expect devices to offer precise temperature control, rapid attainment of therapeutic targets, and minimal interference with concurrent interventions. At the same time, engineering advances and materials science have enabled less invasive surface cooling options and more sophisticated intravascular catheters, each with distinct clinical trade-offs. In parallel, health systems face pressure to demonstrate value through improved patient outcomes and streamlined care pathways, which places device selection squarely in the domain of multidisciplinary committees rather than singular buyer groups. Consequently, purchasing decisions hinge on comparative clinical data, compatibility with temperature monitoring systems, and long-term serviceability.

Looking ahead, the introduction of interoperable platforms and the maturation of evidence from multicenter clinical programs will continue to shape procurement criteria. Transitional developments in standards, reimbursement policy, and clinician training are likely to amplify the importance of comprehensive implementation planning. Therefore, decision-makers must weigh clinical benefits alongside operational impacts to ensure that device adoption translates into measurable improvements at the bedside.

How evolving clinical evidence, device innovation, and hospital operational priorities are collectively reshaping procurement and deployment of therapeutic hypothermia systems

The therapeutic hypothermia landscape has experienced several transformative shifts driven by clinical evidence, device innovation, and systems-level imperatives. First, clinical practice has moved from broad application toward increasingly targeted temperature management, informed by randomized trials and nuanced guideline updates that emphasize patient selection and timing. This clinical refinement has raised the bar for device performance: precision, rapid induction, and controlled rewarming have become core differentiators.

Second, technological progress has expanded the device toolkit. Improvements in catheter design, thermal exchange efficiency, and surface cooling materials have enabled a broader set of clinical scenarios to be addressed with lower procedural risk. Concurrently, digital integration-such as connectivity with electronic health records and remote monitoring capabilities-has begun to unlock workflow efficiencies and enable better adherence to protocols. These capabilities have altered procurement conversations, shifting focus from standalone device features to platform-level compatibility and lifecycle services.

Third, operational realities within hospitals, including constrained ICU capacity and heightened attention to infection prevention, have accelerated interest in less invasive and more modular cooling solutions. Hospitals are increasingly evaluating how hypothermia systems align with broader programs in resuscitation, neurocritical care, and perioperative management. As a result, partnerships between clinicians, biomedical engineering teams, and supply chain leaders have become more strategic, emphasizing evidence of clinical benefit alongside total cost of ownership and implementation support. Together, these shifts have recalibrated expectations for industry participants and clinical adopters alike.

An assessment of how 2025 tariff adjustments prompted near-term supply chain adaptations and strategic procurement shifts across manufacturers and healthcare providers

Tariff changes announced in 2025 have introduced a new layer of complexity for device manufacturers, distributor networks, and health systems, affecting cross-border supply chains and procurement strategies. In response, manufacturers have reassessed manufacturing footprints, sourcing strategies, and pricing models to preserve supply continuity while managing margin pressure. For hospitals and purchasing consortia, the immediate imperative has been to re-evaluate tender specifications and to strengthen local inventory buffers to mitigate potential lead-time variability.

These changes have prompted near-term commercial realignments such as renegotiated distribution agreements and increased use of regional assembly or final configuration centers to reduce tariff exposure. At the same time, device developers have intensified efforts to localize key components and to secure alternative suppliers for thermally conductive materials and electronics. From an operational perspective, clinical teams and procurement professionals have increased scrutiny of total landed cost and logistics risk, and they now factor tariff volatility into multi-year capital planning.

In the medium term, the tariff environment has encouraged stakeholders to explore creative contracting approaches, including value-based procurement arrangements and consortia purchasing that leverage scale. Additionally, there is growing emphasis on service contracts and refurbishment programs to extend device life cycles and offset capital expenditures. Ultimately, while tariffs have introduced short-term friction, they have also accelerated strategic conversations around nearshoring, inventory resilience, and diversified sourcing that may strengthen supply chains over time.

Deep segmentation analysis illuminating how product types, cooling modalities, clinical applications, end users, and temperature control approaches drive differentiated device strategies and clinical adoption

Segmentation insights reveal differentiated adoption patterns and product strategies across the therapeutic hypothermia landscape, reflecting distinct clinical needs and operational constraints. Product type differentiation captures a spectrum from blanket systems and pad systems to water circulation systems and ice or gel packs, with catheter-based systems occupying a critical niche for invasive targeted cooling. Within catheter-based approaches, balloon-based catheters and fluid-based catheters present different insertion profiles and heat-exchange mechanics that influence clinician preference in high-acuity settings.

Cooling method segmentation draws a clear technical divide between intravascular cooling and surface cooling, where intravascular devices offer direct core temperature modulation and surface approaches-embodied by blanket systems, ice packs and gel packs, pad systems, and water circulation systems-provide noninvasive alternatives that integrate readily into existing workflows. Application-focused segmentation maps the clinical use cases that drive demand: cardiac arrest and neonatal encephalopathy remain high-priority scenarios for targeted temperature management, while post-surgical care, stroke, and traumatic brain injury represent growing areas where hypothermia protocols are evaluated for neuroprotection and recovery optimization.

End-user segmentation highlights where implementation complexity and purchasing authority diverge, spanning ambulatory care centers, homecare settings, hospitals, and specialty clinics, each with distinctive operational capabilities and clinical staffing models. Temperature control type segmentation draws attention to controlled temperature management versus uncontrolled cooling, with the former further refined into targeted hypothermia and targeted normothermia strategies that require different device control fidelity and alarm management. Taken together, these segmentation lenses underscore that clinical indication, care setting, and preferred cooling modality co-determine device selection and commercialization approaches.

A comparative regional perspective showing how distinct regulatory, clinical, and supply chain dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific shape device adoption pathways

Regional dynamics exhibit distinct drivers that influence adoption, reimbursement, and supply chain strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced critical care infrastructure and consolidated purchasing networks enable quicker uptake of higher-cost precision devices, while regional centers of excellence for post-resuscitation care often lead evidence generation and best-practice dissemination. Consequently, procurement cycles frequently incorporate clinical outcomes data and require robust service and training offerings to support deployment across sprawling hospital systems.

Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks and reimbursement pathways vary considerably between markets, which in turn affects the commercialization approach. In many EMEA countries, public healthcare procurement emphasizes long-term value and interoperability, prompting manufacturers to demonstrate workflow integration and durable service plans. Additionally, regional clinical societies and collaborative research networks play a pivotal role in shaping guidelines that inform device selection.

In the Asia-Pacific region, rapid expansion of acute care capacity, coupled with increasing investment in neonatal and neurocritical services, has created strong demand for scalable, cost-effective cooling solutions. Supply chain localization and regional partnerships are commonly used to reduce lead times and adapt pricing models to diverse market segments. Across all regions, cross-border collaboration on clinical studies and shared registries is fostering more consistent evidence standards, which supports broader diffusion of best practices and technologies.

A clear-eyed examination of competitive archetypes, strategic priorities, and partnership models that define how companies compete and collaborate in therapeutic hypothermia

Competitive dynamics in therapeutic hypothermia underscore three strategic archetypes among industry participants: large diversified medical device firms leveraging scale and service networks, specialized device manufacturers focused on core cooling technologies, and agile startups driving material or software innovations. Large firms tend to prioritize seamless integration with hospital infrastructure, comprehensive training programs, and extensive post-sales support to win enterprise-level contracts. They also place emphasis on regulatory compliance and global distribution, enabling broad clinical trials and multi-market rollouts.

Specialized manufacturers concentrate on iterative improvements to thermal exchange efficiency, catheter design, or surface cooling ergonomics, targeting clinical niches where technical performance can yield measurable outcome improvements. These companies often collaborate closely with leading clinical centers to validate device efficacy and refine protocols. Meanwhile, startups are more likely to introduce disruptive concepts such as novel heat-exchange materials, modular systems for hybrid cooling strategies, or software-driven control systems that deliver advanced automation and analytics for temperature management.

Across these archetypes, strategic priorities converge on demonstrable clinical benefit, cost-effective service models, and managed risk through quality systems and regulatory pathways. Partnerships between device firms and clinical networks, along with creative commercial models such as leasing, refurbishment, and outcome-linked contracts, are increasingly used to accelerate adoption and to align commercial incentives with clinical outcomes.

Actionable, high-impact recommendations for manufacturers and healthcare leaders to accelerate safe adoption, strengthen supply resilience, and demonstrate clinical value in therapeutic hypothermia

Industry leaders should pursue a coordinated agenda that balances clinical efficacy, operational fit, and financial sustainability to expand adoption and improve patient outcomes. First, manufacturers must prioritize interoperability and clinician-centered design by ensuring devices integrate with monitoring platforms and electronic health records, thereby reducing cognitive load and enhancing protocol adherence. Investing in modular product architectures and scalable training programs will enable rapid customization for different care settings and improve time-to-clinical-impact during rollouts.

Second, stakeholders should deepen clinical evidence generation through multicenter registries and pragmatic studies that reflect real-world practice. Such evidence will support adoption in indications where benefit remains debated and will inform payers and procurement committees evaluating long-term value. Third, supply chain resilience must be reinforced by diversifying component suppliers and adopting regional assembly strategies to mitigate tariff and transportation risks. Contract innovations such as outcome-linked agreements and service-inclusive pricing can align incentives across providers and vendors, making high-performance systems more accessible.

Finally, health systems and vendors should collaborate to create standardized implementation toolkits that include training curricula, protocol templates, and audit mechanisms. These resources will reduce variability in clinical practice and accelerate safe, consistent deployment. By combining technological refinement with operational support and evidence generation, industry leaders can position therapeutic hypothermia systems as reliable, high-impact elements of critical care pathways.

A transparent mixed-methods research approach combining clinician interviews, technical assessments, and supply chain analysis to ensure robust and actionable insights

The research methodology applied a mixed-methods approach designed to triangulate clinical practice patterns, technology trends, and supply chain developments. Primary data inputs were gathered through structured interviews with clinical leads, biomedical engineers, procurement officers, and product managers, supplemented by observational assessments of device deployment in representative care settings. Secondary inputs included peer-reviewed clinical literature, regulatory filings, device instructions for use, and technical white papers that elucidate device operating principles and performance characteristics.

Analytical techniques included qualitative coding of interview transcripts to surface recurring implementation challenges and thematic priorities, alongside comparative technical assessments to evaluate device feature sets and control capabilities. Supply chain analysis incorporated review of tariff measures, public import/export data, and observed manufacturer announcements related to manufacturing shifts or distributor agreements. Throughout the process, validity checks were applied via cross-referencing of independent sources and follow-up clarifications with key informants to mitigate bias and ensure factual accuracy.

Limitations were explicitly acknowledged, including variability in regional clinical practice and the evolving nature of evidence in certain applications. Where applicable, recommendations were tempered by sensitivity analyses and were framed to remain relevant across a range of operational and regulatory scenarios.

A decisive conclusion synthesizing how clinical integration, implementation rigor, and strategic commercialization will determine who succeeds in the therapeutic hypothermia arena

In conclusion, therapeutic hypothermia systems stand at a strategic inflection point where clinical maturation, engineering innovation, and operational demands intersect. The future trajectory of the field will be determined not only by device-level performance but by the ability of manufacturers and health systems to integrate technology into care pathways, to generate real-world evidence, and to manage supply chain complexity. Success will favor organizations that align product design with clinician workflows, bolster implementation support, and engage in collaborative evidence generation.

Operationally, hospitals that adopt a programmatic approach-combining protocol standardization, staff training, and post-implementation auditing-are more likely to realize consistent clinical benefits. Commercially, vendors that emphasize interoperability, service reliability, and flexible contracting will resonate with sophisticated procurement committees. Finally, policy and reimbursement clarity will be a critical accelerant where payers recognize the potential for improved neurological outcomes and reduced long-term care needs. Stakeholders that act decisively on these interrelated imperatives will be well placed to turn promising technology into measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of automated temperature control with real-time patient monitoring to enhance precision in neuroprotection
  • 5.2. Development of portable and wearable hypothermia devices for prehospital emergency care implementation
  • 5.3. Adoption of noninvasive cooling technologies leveraging advanced materials for targeted organ preservation
  • 5.4. Emergence of AI-driven protocols optimizing cooling rates based on individual patient metabolic profiles
  • 5.5. Expansion of global reimbursement frameworks supporting therapeutic hypothermia in post-cardiac arrest care
  • 5.6. Clinical trials assessing combined pharmacologic interventions and hypothermia for enhanced neuroprotective synergy
  • 5.7. Strategic partnerships between device manufacturers and healthcare systems for streamlined hypothermia therapy deployment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Therapeutic Hypothermia Systems Market, by Product Type

  • 8.1. Blanket Systems
  • 8.2. Catheter-Based Systems
    • 8.2.1. Balloon-Based Catheters
    • 8.2.2. Fluid-Based Catheters
  • 8.3. Ice Packs & Gel Packs
  • 8.4. Pad Systems
  • 8.5. Water Circulation Systems

9. Therapeutic Hypothermia Systems Market, by Cooling Method

  • 9.1. Intravascular Cooling
  • 9.2. Surface Cooling
    • 9.2.1. Blanket Systems
    • 9.2.2. Ice Packs & Gel Packs
    • 9.2.3. Pad Systems
    • 9.2.4. Water Circulation Systems

10. Therapeutic Hypothermia Systems Market, by Application

  • 10.1. Cardiac Arrest
  • 10.2. Neonatal Encephalopathy
  • 10.3. Post Surgery
  • 10.4. Stroke
  • 10.5. Traumatic Brain Injury

11. Therapeutic Hypothermia Systems Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Homecare Settings
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Therapeutic Hypothermia Systems Market, by Temperature Control Type

  • 12.1. Controlled Temperature Management
    • 12.1.1. Targeted Hypothermia
    • 12.1.2. Targeted Normothermia
  • 12.2. Uncontrolled Cooling

13. Therapeutic Hypothermia Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Therapeutic Hypothermia Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Therapeutic Hypothermia Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Stryker Corporation
    • 16.3.2. C.R. Bard, Inc.
    • 16.3.3. ZOLL Medical Corporation
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Dragerwerk AG & Co. KGaA
    • 16.3.6. Koninklijke Philips N.V.
    • 16.3.7. Fisher & Paykel Healthcare Corporation Limited
    • 16.3.8. Haemonetics Corporation
    • 16.3.9. Arizant Healthcare Inc.
    • 16.3.10. Cincinnati Sub-Zero Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BALLOON-BASED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY FLUID-BASED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY INTRAVASCULAR COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY BLANKET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY ICE PACKS & GEL PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PAD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY WATER CIRCULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL ENCEPHALOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED HYPOTHERMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TARGETED NORMOTHERMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY UNCONTROLLED COOLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY TEMPERATURE CONTROL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CONTROLLED TEMPERATURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CATHETER-BASED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY SURFACE COOLING, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

TABLE